Integrating Unani principles in the understanding and management of non-alcoholic fatty liver disease: a review

Saquib Raza; Nazim Ali; Fasihuddeen

doi:10.18203/2320-6012.ijrms20260653

Authors

Saquib Raza Department of Ilmul Jarahat State Takmeel-ut-Tib College and Hospital Lucknow Uttar Pradesh, India
Nazim Ali Department of Amraz-e-Jild Wa Tazineeyat State Unani Medical College and H.A.H.R.D.M Hospital Himmatganj Prayagraj Uttar Pradesh, India
Fasihuddeen Department of Ilaj-Bit-Tadbeer State Unani Medical College and H.A.H.R.D.M Hospital Himmatganj Prayagraj Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20260653

Keywords:

NAFLD, Ghair khamri tashahhumm-e-kabid, Warme kabid, Unani medicine, Hepatoprotective herbs

Abstract

Non-Alcoholic Fatty Liver Disease (NAFLD) is a major cause of chronic liver dysfunction globally, affecting nearly 25% of the world’s population. In India, its prevalence ranges from 9% to 32%, with higher occurrence among individuals who are obese or have diabetes mellitus, insulin resistance, hyperlipidaemia, or a sedentary lifestyle. NAFLD encompasses a wide pathological spectrum, beginning with simple hepatic steatosis and potentially progressing to non-alcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma. The disease is strongly associated with mechanisms such as insulin resistance, disturbed lipid metabolism, oxidative stress, inflammation, and hepatic fibrosis. Despite extensive research, modern medicine currently lacks a definitive pharmacological therapy, which has led to growing interest in traditional medical systems, including Unani medicine. According to Unani principles, NAFLD referred to as Ghair Khamri Tashahhum-e-Kabid arises from derangement of the hepatic temperament (Mizaj) and imbalance of humors, particularly an excess of Balgham and Sauda. This imbalance results in obstruction and accumulation of morbid matter within the liver. Common clinical features include fatigue, a feeling of heaviness in the right hypochondrium, impaired digestion, and changes in temperament. Management in Unani medicine aims to restore humoral balance through Ilaj-bil-Ghiza (dietotherapy), Ilaj-bit-Tadbeer (regimental therapy), and Ilaj-bil-Dawa (pharmacotherapy). Several Unani medicinal plants, such as Afsanteen (Artemisia absinthium), Darchini (Cinnamomum zeylanicum), and Mako (Solanum nigrum), possess hepatoprotective, antioxidant, and anti-inflammatory properties that are relevant to the management of NAFLD. Thus, Unani medicine offers a holistic conceptual framework for understanding liver disorders analogous to NAFLD. Integrating classical Unani knowledge with contemporary scientific research on metabolic and herbal mechanisms may provide effective preventive and therapeutic approaches. However, further clinical studies are required to validate the efficacy and safety of Unani interventions in the management of NAFLD.

Metrics

Metrics Loading ...

References

Walker BR, Colledge NR, Ralston SH, Penman ID. Davidson’s Principles and Practice of Medicine. Edinburgh: Churchill Livingstone/Elsevier. 2014;961.

Loscalzo J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. Harrison’s Principles of Internal Medicine. McGraw-Hill. 2022;2619-20.

Antunes C, Azadfard M, Hoilat GJ, Gupta M. Fatty Liver Disease In: StatPearls. 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK441992/. Accessed on 06 December 2025.

Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Non-alcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37(4):917-23. DOI: https://doi.org/10.1053/jhep.2003.50161

NY Post. Lack of sleep linked to fatty liver risk, study finds. New York: NY Post. 2024. Available at: https://nypost.com/2024/04/17/health/lack-of-sleep-could-be-a-factor-in-a-silent-epidemic-shares-the-same-effects-of-alcoholism-expert/?. Accessed on 06 December 2025.

Hasan S, Anwar AI, Farha S. The Comprehensive Review of the Preventive facet of Fatty Liver Disease under the Paradigm of Unani Medicine. J Drug Delivery Ther. 2025;15(7):225-32. DOI: https://doi.org/10.22270/jddt.v15i7.7263

Ansari NN. Therapeutic potential of herbal medicine in NAFLD. Front Pharmacol, 2020;11:603926.

Mayo Clinic. Non-alcoholic fatty liver disease – Symptoms and causes. Mayo Clinic. 2025. Available at: https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/symptoms-causes/syc-20354567?. Accessed on 06 December 2025.

Rangachari B, Murugesan M, Shanmugam C, Gopalsamy S, Chinnadurai KK. Indian literature review on Non-alcoholic Fatty Liver Disease. Gastroenterol Hepatol Endosc Pract. 2024;4(1):10-6. DOI: https://doi.org/10.4103/ghep.ghep_23_23

Goldman L, Schafer AI. Goldman-Cecil Medicine. PA: Elsevier. 2024;1031.

Rabban TAH. Firdausul Hikmat. Idara Kitabu-us-Shifa, New Delhi. 2002;206.

Ibn Sina. Al-Qanun fi’l-Tibb. New Delhi: Idara Kitab-us-Shifa. 2010;856.

Jurjani I. Zakhira Khawarzam Shahi. New Delhi: Idara Kitab-us-Shifa. 2010;378-9.

Siddique M, Akhtar S, Ali I, Khan B. Understanding of Non-Alcoholic Fatty Liver Disease (NAFLD) in Unani System of Medicine: A Co-relational Study with Modern Medical Science. Scope. 2025 ;15(2):503-9.

Razi AMBZ. Kitab al-Hawi. New Delhi: Central Council for Research in Unani Medicine (CCRUM), Ministry of Health and Family Welfare, Govt. of India. 1999. Available at: https://ccrum.res.in/?. Accessed on 06 December 2025.

Ibn Zuhr AM. Kitab al-Aghdhiya. New Delhi: CCRUM Ministry of Health and Family welfare, Government of India. 1986;114-5.

Jurjani, I. Shahi ZK. New Delhi: Idara Kitab-us-Shifa. 2010;372.

Khan M. Al-Akseer. New Delhi: Idara Kitab-us-Shifa. 2011.

Ansari S, Siddiqui MA, Zaman F. Therapeutic principles of liver diseases in Unani medicine. J Res Educ Indian Med. 2015;21:101-5.

Rabban TAH. Firdausul Hikmat,Idara Kitabu-us-Shifa,New Delhi. 2010;208.

Khan MA. Al-Akseer-e-Aza. Idara Kitab-us-Shifa; New Delhi. 2011;484. Available at: https://idarakitabulshifa.com/. Accessed on 06 December 2025.

Razi AMBZ. Al Hawi Fit Tib. New Delhi. CCRUM. 1999;47-98.

Shah MH. The General Principles of Avicenna’s Canon of Medicine: New Delhi. Idara Kitabul Shifa. 2007;429-36.

Baghdadi IH. Kitab-ul-Mukhtarat fit Tibb. CCRUM. 2005;79-91.

Ibn Sina. Al-Qanun fi’l-Tibb. Ghulam Husnain Kantoori. New Delhi: Idara Kitab-us-Shifa. 2010;855.

Husain M. Makhzanul Advia. New Delhi: Idarae Kitab-us-Shifa. 2002. Available at: https://idarakitabulshifa.com/?. Accessed on 06 December 2025.

Ahmed NZ, Siddiqui MA. Safety and efficacy of Afsanteen (Artemisia absinthium L.) in fatty liver: A randomized single blind controlled study. Int J Adv Pharm Med Bioallied Sci. 2015;3(2):106-12.

Askari F, Rashidkhani B, Hekmatdoost A. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high‑sensitivity C‑reactive protein in nonalcoholic fatty liver disease patients. Nutr Res. 2014;34(2):143-8. DOI: https://doi.org/10.1016/j.nutres.2013.11.005

Khan AA, Akhtar MW, Azmi G, Nikhat S. Decrease in shear wave elastography values and associated risk factors in patients of NAFLD with Unani treatment: clinical case series. Explore (NY). 2025;21(6):103243. DOI: https://doi.org/10.1016/j.explore.2025.103243

Derouiche S, Zeghib K, Gharbi S, Khelef Y. Protective effects of Aristolochia longa and Aquilaria malaccensis against lead‑induced acute liver injury in rats. J Acute Dis. 2017;6(5):193-7. DOI: https://doi.org/10.4103/2221-6189.219611

Moravej SAA, Shojaii A, Hashem Dabaghian F, Jazayeri SF, Moravej SZ, Khadem E, et al. The Efficacy of Rosa damascena on Liver Enzymes in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Clinical Trial. Evid Based Complement Alternat Med. 2021;2021:6628911. DOI: https://doi.org/10.1155/2021/6628911

Chang JJ, Chung DJ, Lee YJ, Wen BH, Jao HY, Wang CJ. Solanum nigrum polyphenol extracts inhibit hepatic inflammation, oxidative stress, and lipogenesis in high‑fat‑diet‑treated mice. J Agric Food Chem. 2017;65(42):9255-65. DOI: https://doi.org/10.1021/acs.jafc.7b03578

Rehman H, Begum W, Anjum F, Tabasum H. Rheum emodi (Rhubarb): A Fascinating Herb. J Pharmacogn Phytochem. 2014;3(2):89‑94.

Khan AM, Haque SU, Fatema M. Mastagi (Pistacia lentiscus Linn.): Plant origin drug of Unani medicine: A review. Int J Pharmacogn Clin Res. 2024;6(1):38-43. DOI: https://doi.org/10.33545/2664763X.2024.v6.i1a.48

Mashmoul M, Azlan A, Mohtarrudin N, Mohd Yusof BN, Khaza’ai H, Khoo HE, et al. Protective effects of saffron extract and crocin supplementation on fatty liver tissue of high‑fat diet‑induced obese rats. BMC Complement Altern Med. 2016;16:401. DOI: https://doi.org/10.1186/s12906-016-1381-9

Noshahr NZ, Hadjzadeh MA, Marjaneh MR, Rad KA. The hepatoprotective effects of fennel seeds extract and trans‑Anethole in streptozotocin‑induced liver injury in rats. Food Sci Nutr. 2021;9(2):1121-31. DOI: https://doi.org/10.1002/fsn3.2090

Baghdadi IH. Kitab al-Mukhtarat fil-Tib. II. CCRUM. 2005. Available at: https://www.exoticindiaart.com/book/details/kitab-al-mukhtarat-fit-tibb-part-ii-urdu-ubc972/?. Accessed on 06 December 2025.

Department of AYUSH, Ministry of Health and Family Welfare, Government of India. National Formulary of Unani Medicine. Ministry of AYUSH, Government of India. 2006-2011. Available at: https://www.exoticindiaart.com/book/details/national-formulary-of-unani-medicine-nag923/?. Accessed on 06 December 2025.

Arzani MA. Qarabadeen-e-Qadri. CCRUM. 2009. Available at: https://ccrum.res.in/?. Accessed on 06 December 2025.

Government of India, Ministry of Health and Family Welfare, Department of AYUSH. Unani Pharmacopoeia of India. CCRUM. 2010. Available at: https://wvw.zlibrary.to/dl/the-unani-pharmacopoeia-of-india-part?. Accessed on 06 December 2025.